Results 191 to 200 of about 67,931 (327)

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Ventricular assist devices.

Annals of cardiothoracic surgery, 2014
Chris, Harris, Beth, Croce, Ashleigh, Xie   +2 more
openaire   +3 more sources

Vasoplegia after implantation of a continuous flow left ventricular assist device: incidence, outcomes and predictors [PDF]

, 2018
Eric E.C. de Waal, Bas van Zaane, Marnix M. van der Schoot, Albert Huisman, Faiz Ramjankhan, Wilton A. van Klei, Nándor Marczin   +6 more
openalex   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

A fully magnetically levitated left ventricular assist device — final report [PDF]

, 2019
Ewald, G.A., Itoh, A.
core   +1 more source

Active Implantable cardioverter-defibrillators in Continuous-flow Left Ventricular Assist Device Recipients Electrophysiology Collaborative Consortium for Metaanalysis – ELECTRAM Investigators

, 2020
Kuldeep Shah
openalex   +1 more source

Implementation of guideline‐recommended medical therapy for patients with heart failure in Europe

ESC Heart Failure, Volume 12, Issue 2, Page 790-798, April 2025.
Abstract Physicians' adherence to guideline‐recommended heart failure (HF) treatment remains suboptimal, especially regarding the target doses. In particular, there is evidence that non‐cardiologists are less compliant with HF guideline recommendations. This is likely to have a detrimental impact on patients' survival, readmissions and quality of life.
Maurizio Volterrani, Petar Seferovic, Gianluigi Savarese, Ilaria Spoletini, Egidio Imbalzano, Antoni Bayes‐Genis, Ewa Jankowska, Michele Senni, Marco Metra, Ovidiu Chioncel, Andrew J. S. Coats, Giuseppe M. C. Rosano   +11 more
wiley   +1 more source

Hemodynamic consequences of pressure-flow curve gradient variations in continuous-flow ventricular assist devices. [PDF]

Front Physiol
Yang Y, Wang Z, Xie Z, Yu S, Zou L.
europepmc   +1 more source

Ventricular assist device bridging with gender-mismatch increases rejection and decreases survival following a heart transplant [PDF]

, 2020
Yoshifumi Itoda, Toshihiro Okamoto, Hiromichi Niikawa, K.S. Ayyat, Chao Tu, Kenneth R. McCurry   +5 more
openalex   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source